Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists

Author(s):  Cutter Christopher B

Issue:  Nov/Dec 2000 - Compounding for Hormone Replacement Therapy
View All Articles in Issue

Abstract:  In this article, the author reviews the basic pathophysiological mechanisms of hypogonadism, emphasizing the role of the compounding pharmacist in the case of these special patients. Regarding compounding gels, he reports on a clinical study involving 10 men that he conducted in 1988 showing that compounded testosterone gels (Pluronic lecithin organogel) or an alcohol-based gel was highly effective and met with high patient acceptance. Patients were withdrawn from their previous testosterone therapy and had baseline levels of hormones measured 2-4 weeks later. Therapy was initiated with testosterone Pluronic lecithin organogel at low doses (1% to 1.5%, 1 to 2 mL) applied at bedtime. Serum levels of total and free testosterone were drawn at weekly intervals, and the amount or concentration of the testosterone gel was then increased as needed. Although some begin to exhibit therapeutic levels of testosterone at the initial dose, most required much higher concentrations (up to 10%). After doses had been titrated upward for 2 weeks, all subjects exhibited adequate therapeutic levels of total androgens. However, results demonstrated great intra- and interpatient variation in response to therapy, so monitoring serum hormone levels was essential for proper titration of the dose. An estimated absorption efficiency of the gels was from 6% to 50% of the applied amount. The author also discusses percutaneous therapy, application site and patient monitoring. He concludes that testosterone gels are effective when properly used and that monitoring the levels of androgens and estrogen enables the physician to determine the effectiveness of the prescribed dosage and application site. Compounded preparations have the advantages of providing dosing flexibility and being priced very reasonably. Tables provide information regarding causes of primary and secondary hypogonadism, disease states associated with hypogonadism, medication and factors associated with hypogonadism, symptoms and

Related Keywords: decreased libido, hypogonadism, percutaneous testosterone, sexual dysfuction, testosterone, testosterone gel, topical testosterone


Printer-Friendly Version

Download in electronic PDF format for $65

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists Cutter Christopher B Nov/Dec 2000 432-437 View Sample
Case Study: Absorption of Testosterone Cream via Scrotal Delivery Needham Shawn, Needham Shane Nov/Dec 2018 466-468 Buy
Testosterone Deficiency in Men: New Treatments for Andropause Biundo Bruce, Shippen Eugene Nov/Dec 2000 429-431 Buy
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Guth Michael AS May/Jun 2015 195-203 Buy
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Lehman Paul A, Raney Sam G May/Jun 2012 248-252 Buy
Testosterone Cypionate 100-mg/mL Injection Allen Loyd V Jr Jan/Feb 2013 73 Buy
Testosterone Levels in an Aging Population: Screen, Measure, and Restore Kells John, DollbaumCharles M Mar/Apr 2011 102-112 Buy
Testosterone Enanthate 200-mg/mL Injection Allen Loyd V Jr Mar/Apr 2014 151 Buy
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy Glaser Rebecca L, York Anne E Jul/Aug 2019 325-339 Buy
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography Gupta Vishnu D Mar/Apr 1999 158-159 Buy
Particle Measuring Systems - USP <797> Environmental Monitoring Solutions